Dihydrotestosterone induces minor transcriptional alterations in genital skin fibroblasts of children with and without androgen insensitivity.


Journal

Endocrine journal
ISSN: 1348-4540
Titre abrégé: Endocr J
Pays: Japan
ID NLM: 9313485

Informations de publication

Date de publication:
25 Apr 2019
Historique:
pubmed: 23 2 2019
medline: 18 12 2019
entrez: 22 2 2019
Statut: ppublish

Résumé

Endogenous and exogenous androgens induce masculinization of external genitalia through binding to the androgen receptor (AR). The target genes of androgens in external genitalia remain to be determined, although previous studies have shown that the apolipoprotein D gene (APOD) was significantly upregulated by dihydrotestosterone (DHT), the most potent androgen in humans. In the present study, we performed microarray analysis for genital skin fibroblasts obtained from four boys with buried penis (the control individuals) and a patient with partial androgen insensitivity syndrome (PAIS) due to a hypomorphic mutation in AR (the PAIS patient). We identified 24 transcripts that were upregulated or downregulated by DHT in all samples of control individuals and, to a lesser extent, in the sample of the PAIS patient. Differences between DHT-treated and -untreated samples were small; the results of 24 transcripts did not reach statistical significance. The 24 transcripts included CYP1B1, a gene possibly involved in the development of genital tubercle in mice, and APOD, as well as several genes that have been reported as androgen targets in prostate or other tissues. The results of this study indicate that androgen-mediated masculinization of external genitalia is unlikely to depend on massive transcriptional changes in specific AR target genes. Rather, minor transcriptional changes of several genes, and/or a complex molecular network may play a major role in penile development. Importantly, our data suggest the possible involvement of CYP1B1 in human genital development and confirm the clinical importance of APOD as a biomarker for AR function.

Identifiants

pubmed: 30787207
doi: 10.1507/endocrj.EJ18-0494
doi:

Substances chimiques

Androgens 0
Receptors, Androgen 0
Dihydrotestosterone 08J2K08A3Y

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

387-393

Auteurs

Kanako Tanase-Nakao (K)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.
Department of Advanced Pediatric Medicine, Tohoku University School of Medicine, Tokyo 157-8535, Japan.

Kentaro Mizuno (K)

Department of Pediatric Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.

Yutaro Hayashi (Y)

Department of Pediatric Urology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan.

Yoshiyuki Kojima (Y)

Department of Urology, Fukushima Medical University School of Medicine, Fukushima 960-1295, Japan.

Mariko Hara (M)

Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Kenji Matsumoto (K)

Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Yoichi Matsubara (Y)

Department of Advanced Pediatric Medicine, Tohoku University School of Medicine, Tokyo 157-8535, Japan.
Institute director, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Maki Igarashi (M)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Mami Miyado (M)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Maki Fukami (M)

Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo 157-8535, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH